OMIM |
OMIM:616649 |
SPHEROCYTOSIS, TYPE 2; SPH2 |
— |
— |
— |
OMIM |
OMIM:616651 |
ROIFMAN SYNDROME; RFMN |
— |
— |
— |
OMIM |
OMIM:616652 |
YUAN-HAREL-LUPSKI SYNDROME; YUHAL |
— |
— |
— |
OMIM |
OMIM:616654 |
JOUBERT SYNDROME 24; JBTS24 |
— |
— |
— |
OMIM |
OMIM:616657 |
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM |
— |
— |
— |
OMIM |
OMIM:616668 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X |
— |
— |
— |
OMIM |
OMIM:616669 |
IMMUNODEFICIENCY 45; IMD45 |
— |
— |
— |
OMIM |
OMIM:616672 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27 |
— |
— |
— |
OMIM |
OMIM:616680 |
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE; SPG75 |
— |
— |
— |
OMIM |
OMIM:616681 |
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16 |
— |
— |
— |
OMIM |
OMIM:616682 |
SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME; SSMS |
— |
— |
— |
OMIM |
OMIM:616683 |
LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12 |
— |
— |
— |
OMIM |
OMIM:616684 |
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K |
— |
— |
— |
OMIM |
OMIM:616685 |
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14 |
— |
— |
— |
OMIM |
OMIM:616687 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y |
— |
— |
— |
OMIM |
OMIM:616688 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z |
— |
— |
— |
OMIM |
OMIM:616689 |
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2 |
— |
— |
— |
OMIM |
OMIM:616697 |
DEAFNESS, AUTOSOMAL DOMINANT 69; DFNA69 |
— |
— |
— |
OMIM |
OMIM:616705 |
DEAFNESS, AUTOSOMAL RECESSIVE 97; DFNB97 |
— |
— |
— |
OMIM |
OMIM:616707 |
DEAFNESS, AUTOSOMAL DOMINANT 68; DFNA68 |
— |
— |
— |
OMIM |
OMIM:616708 |
DESANTO-SHINAWI SYNDROME; DESSH |
— |
— |
— |
OMIM |
OMIM:616710 |
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22 |
— |
— |
— |
OMIM |
OMIM:616716 |
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5 |
— |
— |
— |
OMIM |
OMIM:616719 |
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21 |
— |
— |
— |
OMIM |
OMIM:616720 |
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19 |
— |
— |
— |